Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
LP230269-5 Leucine-rich glioma-inactivated protein 1
Leucine-rich glioma-inactivated protein 1 (LGI1) is part of a group of antigens that have target antibodies that bind to neuronal cell surface or synaptic proteins but are not associated with a malignancy. The ensuing encephalitis has been designated neuronal surface antibody syndrome or autoimmune synaptic encephalitis. LGI1 antibodies have been associated with encephalitis that responds well to treatment and has a good expected outcome.[PMID: 25520958] Source: Regenstrief LOINC
LP269367-1 CBA IFA
In cell binding assays or cell-based assays (CBA) also known as cell-based immunoassays, the DNA coding for a particular antigen is transfected into cultured cells, which are then used directly as substrate for antibody detection by immunofluorescence. The advantage of CBA IFA over conventional immunoassays is that purification and stability of the antigen is not required and they provide an in vivo substrate. Source: Regenstrief LOINC
- Leucine-rich glioma-inactivated protein 1 Ab
- CBA IFA
- Short Name
- LGI1 Ab CSF Ql CBA IFA
- Display Name
- Leucine-rich glioma-inactivated protein 1 Ab Cell binding immunofluorescent assay Ql (CSF)
- Consumer Name Alpha
- Leucine-rich glioma-inactivated protein 1 antibody, Spinal fluid
Example Answer List: LL2038-9Source: Quest Diagnostics Inc.
|PositiveCopyright http://snomed.info/sct ID:10828004 Positive (qualifier value)||LA6576-8|
|NegativeCopyright http://snomed.info/sct ID:260385009 Negative (qualifier value)||LA6577-6|
|IndeterminateCopyright http://snomed.info/sct ID:82334004 Indeterminate (qualifier value)||LA11884-6|
- First Released
- Version 2.65
- Last Updated
- Version 2.69
- Order vs. Observation
Member of these Groups
|LOINC Group||Group Name|
|LG51431-1||Leucine-rich glioma-inactivated protein 1 Ab|
|it-IT||Italian (Italy)||Proteina 1 glioma-inattivata ricca di leucina Ab:
|fr-FR||French (France)||LGI1 anticorps:
|es-ES||Spanish (Spain)||Proteína 1 inactivada del glioma rica en leucina Anticuerpos:
|zh-CN||Chinese (China)||富亮氨酸胶质瘤失活蛋白 1 抗体:
|es-MX||Spanish (Mexico)||Proteína 1 Ab inactivada por glioma rica en leucina:
LOINC Terminology Service (API) using
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or firstname.lastname@example.org<mailto:email@example.com>. This may incur a fee in SNOMED International non-Member countries.
Copyright © 2023 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright